$IVZ

TD Cowen Adjusts Price Target on Invesco to $39 From $37, Keeps Buy Rating

TD Cowen raised its price target on Invesco to $39 from $37 and kept a Buy rating, according to the firm. The article also notes that exchange-traded funds were higher and US equities were mixed after midday.

Original reporting
Published Aug 13, 2026, 12:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 3:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$IVZ
Bullish
medium confidence
Mentioned
$IVZ
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$IVZBullishLow
01

Why it matters

For traders, the actionable element is the PT change itself, which may affect short-term positioning and sentiment, but the article provides no new IVZ-specific operating or financial datapoint.

02

Market read

A single analyst target increase for IVZ, likely to be a minor sentiment catalyst rather than a fundamental repricing driver.

03

What to watch

ETF flows, fee compression, and market volatility are likely to dominate IVZ near-term, none of which are addressed in the provided text.

Relevance 4/10Novelty 3/10Timing: pre-market today (08:50 am EDT)

Background

The piece is a marketscreener-style repost of an analyst action, describing TD Cowen’s updated valuation target and rating framework.

Company-level read

Ticker impact

$IVZBullishMedium confidence
Context

TD Cowen raised its Invesco price target to $39 from $37 and kept a Buy rating, signaling a fresh analyst valuation view.

Expected impact

Likely modest positive bias for IVZ shares around the note, with follow-through dependent on broader ETF/asset-management sentiment.

Evidence & confidence

The only disclosed new fact is the analyst price target adjustment; there is no new IVZ earnings, guidance, or operational update in the text.

Market effects

Adds incremental bullishness to the asset-management/ETF complex via a valuation-target reset, but without sector-wide new data.

No specific regional catalyst beyond a US analyst note.

Limited, as the disclosure is US-focused and not tied to global regulatory or macro events.

Counterpoint

Price-target hikes can lag fundamentals; without new IVZ fundamentals, the market may discount the change quickly.

Key entities

  • Invesco

    Subject of the analyst price-target adjustment and maintained Buy rating.

  • TD Cowen

    Brokerage issuing the price target change to $39 from $37.

Related articles

$IVZMedAI 8/10

Invesco Cuts Fees 20% to Stem Property Fund Redemptions

Invesco is reducing management fees by 20% through 2027 for its $12.7B core real estate fund to address high redemption requests. A tender offer at 95% of net asset value and a $150M investment by Invesco and its leaders aim to stabilize the fund. The fund's redemption queue stands at $2.2B, with recent redemption rates higher than historical averages.

$IVZMed

What Invesco (IVZ)'s New Solutions Platform and Real Estate Fee Cuts Mean For Shareholders

Invesco Ltd. launched Invesco Solutions & Custom Strategies, a global platform combining public and private market capabilities, and cut fees on its US$12.70 billion real estate fund. The company aims to address liquidity concerns and enhance investor confidence. Invesco projects $4.7 billion revenue and $1.5 billion earnings by 2029, with some analysts forecasting higher figures.

$IVZMedAI 8/10

Invesco Cuts Fees 20% as Real Estate Fund Faces Queue

Invesco Ltd. reduced management fees by 20% for its $12.7 billion real estate fund, ICRE, to address a $2.2 billion redemption backlog. The firm also offered a tender at a 5% discount and will invest up to $150 million to support the fund. ICRE has seen increased redemption requests, averaging 5.3% of net asset value since 2022, up from 3.5% historically. The moves aim to ease investor concerns amid real estate market challenges.